Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 12 subunit beta (IL-12p40) is a cytokine subunit that is a component of both Interleukin 12 (IL-12) and Interleukin 23 (IL-23). IL-12p40 is crucial for Th1 differentiation and enhancing NK/T-cell cytotoxicity via IL-12, and regulates innate/adaptive immunity via Th17 through IL-23. It may act as an extracellular adapter forming de novo active cytokines
Modulation of IL-12 and IL-23 signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 12 subunit beta (IL-12p40).